(Q55472858)

12 July 2018

title

Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran (English)

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

2 January 2024

author name string

Asa Liljegren Sundberg

1

1 reference

12 July 2018

Erik Blomquist

2

1 reference

12 July 2018

Jörgen Carlsson

3

1 reference

12 July 2018

Ann-Charlott Steffen

4

1 reference

12 July 2018

Lars Gedda

5

1 reference

12 July 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12745022

2 January 2024

publication date

1 April 2003

1 reference

12 July 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0969805102004213?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

https://api.elsevier.com/content/article/PII:S0969805102004213?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

Nuclear Medicine and Biology

2 January 2024

published in

1 reference

12 July 2018

volume

30

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

303-315

1 reference

12 July 2018

The solution structures of epidermal growth factor and transforming growth factor alpha

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Receptors for epidermal growth factor and other polypeptide mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

EGF receptor amplification and expression in human brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Targeting tumor cellsvia EGF receptors: Selective toxicity of an HBEGF-toxin fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Recombinant antibody constructs in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

1-Cyano-4-dimethylamino pyridinium tetrafluoroborate as a cyanylating agent for the covalent attachment of ligand to polysaccharide resins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Expression of epidermal growth factor and its receptor in cirrhotic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Taking engineered anti-CEA antibodies to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Epidermal growth factor receptor and bladder cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Limitations in the use of low pH extraction to distinguish internalized from cell surface-bound radiolabeled antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Endocytosis of growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Irregular variations in radiation sensitivity when the linear energy transfer is increased

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

The design and application of residualizing labels for studies of protein catabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900421-3

7 January 2021

Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects

1

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies

2 January 2024

9

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody

2 January 2024

38

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms

2 January 2024

43

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

In vitro characterization of an end-end coupled mEGF-dextran conjugate using a cultured human glioma cell line

2 January 2024

45

1 reference

https://api.crossref.org/works/10.1016/S0969-8051(02)00421-3

2 January 2024

Identifiers

1 reference

12 July 2018

1 reference

12 July 2018